Related Experiment Video

Updated: Jul 21, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Recurrent pneumococcal bacteremia: 34 episodes in 15 patients

M R Coccia1, R R Facklam, L D Saravolatz

  • 1Ohio State University Medical Center, Columbus, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 13, 1998
PubMed

Insights

Recurrent pneumococcal bacteremia occurred in 15 patients with underlying conditions. Preventive strategies like vaccination and prophylactic antibiotics are recommended for those with recurring pneumococcal disease.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Background:

  • Pneumococcal bacteremia, a serious bloodstream infection, can recur in vulnerable populations.
  • Identifying risk factors and patterns of recurrence is crucial for effective management.

Purpose of the Study:

  • To analyze the incidence, characteristics, and recurrence patterns of pneumococcal bacteremia in Franklin County, Ohio.
  • To evaluate the role of serotyping and genotyping in understanding recurrent infections.
  • To inform preventive strategies for patients at high risk.

Main Methods:

  • Retrospective review of pneumococcal bacteremia cases over five years across multiple hospitals.
  • Serotyping and genotyping of bacterial isolates to identify specific strains.
  • Analysis of patient demographics, predisposing conditions, and treatment outcomes.

Main Results:

  • Fifteen patients experienced 34 episodes of pneumococcal bacteremia, with most having multiple episodes.
  • Common predisposing conditions included lymphoma, multiple myeloma, and chronic obstructive pulmonary disease.
  • Genotyping confirmed recurrence in four patients, with three experiencing early re-infection (22-90 days).
  • Serotype 23F was prevalent, and some isolates showed penicillin non-susceptibility.

Conclusions:

  • Recurrent pneumococcal bacteremia poses a significant challenge, particularly in immunocompromised individuals.
  • Understanding strain characteristics aids in identifying true recurrences.
  • Preventive measures, including pneumococcal conjugate vaccination and prophylactic antibiotics, should be considered for high-risk patients.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...